Our results showed that topical application of CF could mitigate inflammation, show analgesic activity, improve the symptoms of RA model rats, and reduce the levels of serum inflammatory factors IL-6, COX-2, TNF-α, IL-1β, and RF. The gene discussed is PTGS2; the disease is rheumatoid arthritis.